Internal Medicine, Cardiovascular Disease · Las Cruces, NM
NPI
1841365194
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1255 S Tolshor Blvd
Las Cruces, NM, 88011
Phone (505) 522-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$262K
3,649 services
Medicare patients, 2024
571
Average age 76
Drug cost, 2024
$950K
7,772 prescriptions
Company payments, 2025
$35.22
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Guido Leon was code 99214 (office e&m - established), 838 times for 445 patients. In total Guido Leon billed 3,649 services in 60 codes, and Medicare paid $262K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 838 | 445 | $82.65 | $69K |
| 93000 Electrocardiogram | Office | 807 | 426 | $9.36 | $7,550 |
| 99215 Office E&M - Established | Office | 236 | 151 | $119.57 | $28K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 201 | 115 | $8.14 | $1,636 |
| 93015 Electrocardiogram | Office | 176 | 173 | $45.79 | $8,058 |
| 93306 Echocardiography (TTE/TEE) | Office | 165 | 161 | $126.27 | $21K |
| 78452 Myocardial Perfusion Scan | Office | 161 | 161 | $287.59 | $46K |
| 85610 Clinical Chemistry | Office | 153 | 28 | $4.20 | $643 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 142 | 139 | $54.33 | $7,714 |
| 99205 Office E&M - New | Office | 105 | 105 | $138.23 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 71 | 35 | $55.69 | $3,954 |
| 99152 Anesthesia | Facility | 63 | 58 | $8.63 | $544 |
| 99223 Hospital E&M - Initial | Facility | 61 | 53 | $117.95 | $7,195 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 51 | 51 | $120.72 | $6,157 |
| 93288 External Electrocardiographic Monitoring | Office | 50 | 35 | $31.61 | $1,580 |
By year: 2022 $365K for 4,268 services; 2023 $352K for 4,529 services; 2024 $262K for 3,649 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 153 | 28 | $4.20 | $643 |
Medicare prescription drug claims, 2024
In 2024, the drug Guido Leon prescribed most often to Medicare patients was Metoprolol Succinate, with 642 prescriptions and refills. In total Guido Leon wrote 7,772 Medicare prescriptions that cost $950K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 642 | 1,860 | 227 | $9,493 |
| Clopidogrel Clopidogrel Bisulfate | 575 | 1,691 | 192 | $6,572 |
| Potassium Chloride Generic | 444 | 1,232 | 146 | $7,984 |
| Eliquis Apixaban | 391 | 947 | 128 | $537K |
| Olmesartan Medoxomil Generic | 371 | 1,039 | 125 | $5,495 |
| Rosuvastatin Calcium Generic | 307 | 912 | 110 | $4,422 |
| Atorvastatin Calcium Generic | 298 | 856 | 94 | $2,965 |
| Clonidine Hcl Generic | 255 | 741 | 91 | $1,999 |
| Amlodipine Besylate Generic | 249 | 718 | 91 | $1,977 |
| Prasugrel Hcl Generic | 229 | 645 | 74 | $23K |
| Carvedilol Generic | 226 | 630 | 74 | $2,439 |
| Lisinopril Generic | 207 | 584 | 70 | $1,943 |
| Furosemide Generic | 205 | 611 | 77 | $1,195 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 203 | 590 | 76 | $2,508 |
| Spironolactone Generic | 172 | 487 | 63 | $1,656 |
Brand drugs: 762 claims; generic drugs: 7,010 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Guido Leon $35.22 ($35.22 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $19.88.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.